Healthcare Triangle Plans Teyame AI Direct Listing
Analysis based on 6 articles · First reported Sep 03, 2026 · Last updated Sep 03, 2026
The planned separation and direct listing could unlock value for Healthcare Triangle shareholders through the distribution of Teyame AI Holdings Inc. shares, potentially boosting HCTI's stock. The transaction is subject to regulatory approvals, and its success may affect investor sentiment toward both entities.
Healthcare Triangle, Inc. (Nasdaq: HCTI), a healthcare technology company, announced on September 3, 2026, that it has signed a separation agreement with its subsidiary Teyame AI Holdings Inc. Inc. to govern the planned separation of Teyame AI Holdings Inc. from HCTI. The separation agreement addresses the allocation of assets and liabilities, transition services, and other customary terms. In connection with the separation, HCTI plans a direct listing of Teyame AI Holdings Inc.' common stock on Nasdaq. Teyame AI Holdings Inc. holds HCTI's recently acquired AI-powered customer experience businesses, Teyame 360 S.L. and Datono Mediación S.L., which HCTI acquired in January 2026. HCTI's Board of Directors has approved a stock dividend to distribute a minority interest of Teyame AI Holdings Inc.' outstanding common stock to HCTI shareholders. The direct listing is subject to SEC review of a registration statement and Nasdaq approval.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard